Ask OpenScientist

Ask a research question about CYCS-Related Thrombocytopenia. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Mappings
1
Inheritance
3
Pathophys.
1
Phenotypes
7
Pathograph
1
Genes
1
Medical Actions
🏷

Classifications

🔗

Mappings

MONDO
MONDO:0012775 thrombocytopenia 4
skos:exactMatch MONDO
MONDO:0012775 is defined as thrombocytopenia caused by mutation in CYCS and carries the OMIM:612004 cross-reference for thrombocytopenia 4.
👪

Inheritance

1
Autosomal dominant inheritance HP:0000006
THC4 is caused by monoallelic heterozygous CYCS variants segregating with thrombocytopenia in affected pedigrees.
Autosomal dominant inheritance
Show evidence (1 reference)
PMID:38815995 SUPPORT Human Clinical
"Thrombocytopenia 4 (THC4) is an autosomal-dominant thrombocytopenia caused by mutations in CYCS"
Establishes autosomal-dominant inheritance for CYCS-related thrombocytopenia.

Pathophysiology

3
CYCS Missense Variant Alters Cytochrome c
Heterozygous missense variants in CYCS alter somatic cytochrome c, a small mitochondrial heme protein that shuttles electrons in oxidative phosphorylation and also participates in intrinsic apoptotic signaling after mitochondrial release.
CYCS hgnc:19986
respiratory electron transport chain GO:0022904 ↓ DECREASED intrinsic apoptotic signaling pathway GO:0097193 ↑ INCREASED
Show evidence (1 reference)
PMID:38815995 SUPPORT Human Clinical
"Thrombocytopenia 4 (THC4) is an autosomal-dominant thrombocytopenia caused by mutations in CYCS, the gene encoding cytochrome c (CYCS), a small haeme protein essential for electron transport in mitochondria and cell apoptosis."
Identifies CYCS as the causal gene and cytochrome c as an electron-transfer and apoptosis protein.
Reduced Respiration and Increased Apoptotic Activity
Functional studies of thrombocytopenia-associated CYCS variants show reduced respiratory performance alongside increased apoptotic activity. This distinguishes CYCS-related thrombocytopenia from classic Complex IV assembly deficiency: cytochrome c is affected, but patients generally do not show a syndromic cytochrome c oxidase deficiency phenotype.
megakaryocyte CL:0000556
respiratory electron transport chain GO:0022904 ↓ DECREASED positive regulation of apoptotic process GO:0043065 ↑ INCREASED
Show evidence (2 references)
PMID:24326104 SUPPORT In Vitro
"we found reduction of respiratory level and increased apoptotic rate, supporting the pathogenetic role of CYCS in thrombocytopenia."
Yeast and mouse cellular models directly support reduced respiration and increased apoptosis downstream of thrombocytopenia-associated CYCS variants.
PMID:18345000 SUPPORT In Vitro
"The mutation yields a cytochrome c variant with enhanced apoptotic activity in vitro."
The original CYCS G41S study supports enhanced apoptotic activity as a variant effect.
Dysregulated Megakaryocyte Platelet Release
Patient studies indicate that circulating proplatelet formation can remain effective, but CYCS-mutant megakaryocytes also release platelet-like structures prematurely into extravascular bone marrow regions. Platelet-like structures released outside the vascular space lack a normal marginal microtubule coil, making them ineffective contributors to the circulating platelet pool.
megakaryocyte CL:0000556 platelet CL:0000233
platelet formation GO:0030220
Show evidence (2 references)
PMID:27861742 SUPPORT Human Clinical
"the low platelet phenotype in Thrombocytopenia Cargeeg subjects is caused by premature release of platelets into non-vascular regions of the bone marrow."
Patient marrow observations support premature extravascular platelet release as a mechanism for low circulating platelet count.
PMID:27861742 SUPPORT Human Clinical
"platelet-like structures within the extravascular bone marrow space have the dimensions of platelets but lack the marginal microtubule coil, suggesting abnormal proplatelet-independent platelet release."
The abnormal extravascular platelet-like structures provide a tissue-level link from CYCS-mutant megakaryocytes to reduced effective platelet production.

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for CYCS-Related Thrombocytopenia Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.

Phenotypes

1
Thrombocytopenia Hematologic HP:0001873
Show evidence (2 references)
PMID:38815995 SUPPORT Human Clinical
"mild-to-moderate thrombocytopenia, normal platelet size, and function, low risk of bleeding, and no additional clinical phenotypes associated with reduced platelet count."
The largest reported THC4 cohort defines the characteristic platelet phenotype.
PMID:35126455 SUPPORT Human Clinical
"The platelet counts of the patients were varied, ranging from 38 to 110 × 109/L (reference range: 150-450 x 109/L)."
A three-generation CYCS family documents reduced platelet counts in affected individuals.
🧬

Genetic Associations

1
CYCS pathogenic variants causing thrombocytopenia 4
Gene: CYCS hgnc:19986
Autosomal dominant
💊

Medical Actions

1
Genetic Counseling
Action: genetic counseling MAXO:0000079
Counseling for autosomal-dominant transmission and family testing where a pathogenic CYCS variant has been identified.
{ }

Source YAML

click to show
name: CYCS-Related Thrombocytopenia
category: Mendelian
creation_date: "2026-07-06T01:49:38Z"
synonyms:
- Thrombocytopenia 4
- THC4
- CYCS thrombocytopenia
- Autosomal dominant non-syndromic thrombocytopenia 4
- Autosomal isolated thrombocytopenia with normal platelet size
description: >-
  CYCS-related thrombocytopenia (thrombocytopenia 4, THC4) is an
  autosomal-dominant inherited thrombocytopenia caused by heterozygous missense
  variants in CYCS, the nuclear gene encoding somatic cytochrome c. Public
  disease sources anchor OMIM:612004 and ORPHA:168629 to this thrombocytopenia
  entity, not to a cytochrome c oxidase holoenzyme-assembly disorder. The
  disease is mechanistically mitochondrial because cytochrome c transfers
  electrons in the respiratory chain and participates in intrinsic apoptosis,
  but the dominant clinical phenotype is mild-to-moderate isolated
  thrombocytopenia with normal platelet size and low bleeding risk. Model and
  patient-cell data support a dual mechanism: CYCS variants reduce respiratory
  performance and increase apoptotic activity, while megakaryocyte-bone-marrow
  interactions promote premature platelet-like release into extravascular marrow
  space, lowering circulating platelet number.
classifications:
  icimd_category:
  - classification_value: cytochrome_c
    notes: >-
      WP-023 / ICIMD code 8.3.03.01 places this seed under disorders of
      mitochondrial cytochrome c. The curated DisMech disease identity follows
      MONDO:0012775 / OMIM:612004 as CYCS-related thrombocytopenia; it is kept
      separate from the Complex IV deficiency grouping because CYCS encodes the
      soluble electron carrier cytochrome c rather than a COX structural subunit
      or assembly factor.
disease_term:
  preferred_term: CYCS-related thrombocytopenia (THC4)
  term:
    id: MONDO:0012775
    label: thrombocytopenia 4
mappings:
  mondo_mappings:
  - term:
      id: MONDO:0012775
      label: thrombocytopenia 4
    mapping_predicate: skos:exactMatch
    mapping_source: MONDO
    mapping_justification: >-
      MONDO:0012775 is defined as thrombocytopenia caused by mutation in CYCS
      and carries the OMIM:612004 cross-reference for thrombocytopenia 4.
parents:
- Inherited thrombocytopenia
- Mitochondrial Disease
external_assertions:
- name: Orphanet CYCS disease-gene record
  source: Orphanet
  assertion_type: disease_gene_record
  external_id: ORPHA:168629
  url: https://www.orpha.net/en/disease/detail/168629
  description: >-
    Orphanet identifies ORPHA:168629 as autosomal isolated thrombocytopenia with
    normal platelet size and links CYCS as a disease-causing germline gene.
prevalence:
- population: Reported CYCS families
  measure_type: CASES_IN_LITERATURE
  prevalence_class: ULTRA_RARE
  notes: >-
    Published cohorts describe THC4 as extremely rare, with only a few families
    reported before the 2024 expansion series.
  evidence:
  - reference: PMID:38815995
    reference_title: "Thrombocytopenia 4 (THC4): Six novel families with mutations of the cytochrome c gene."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "THC4 is considered an extremely rare condition since only a few patients have been reported so far."
    explanation: The 2024 cohort review supports an ultra-rare, cases-in-literature prevalence characterization.
inheritance:
- name: Autosomal dominant inheritance
  description: >-
    THC4 is caused by monoallelic heterozygous CYCS variants segregating with
    thrombocytopenia in affected pedigrees.
  inheritance_term:
    preferred_term: Autosomal dominant inheritance
    term:
      id: HP:0000006
      label: Autosomal dominant inheritance
  evidence:
  - reference: PMID:38815995
    reference_title: "Thrombocytopenia 4 (THC4): Six novel families with mutations of the cytochrome c gene."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Thrombocytopenia 4 (THC4) is an autosomal-dominant thrombocytopenia caused by mutations in CYCS"
    explanation: Establishes autosomal-dominant inheritance for CYCS-related thrombocytopenia.
pathophysiology:
- name: CYCS Missense Variant Alters Cytochrome c
  role: trigger
  description: >-
    Heterozygous missense variants in CYCS alter somatic cytochrome c, a small
    mitochondrial heme protein that shuttles electrons in oxidative
    phosphorylation and also participates in intrinsic apoptotic signaling after
    mitochondrial release.
  gene:
    preferred_term: CYCS
    term:
      id: hgnc:19986
      label: CYCS
  biological_processes:
  - preferred_term: respiratory electron transport chain
    term:
      id: GO:0022904
      label: respiratory electron transport chain
    modifier: DECREASED
  - preferred_term: intrinsic apoptotic signaling pathway
    term:
      id: GO:0097193
      label: intrinsic apoptotic signaling pathway
    modifier: INCREASED
  evidence:
  - reference: PMID:38815995
    reference_title: "Thrombocytopenia 4 (THC4): Six novel families with mutations of the cytochrome c gene."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Thrombocytopenia 4 (THC4) is an autosomal-dominant thrombocytopenia caused by mutations in CYCS, the gene encoding cytochrome c (CYCS), a small haeme protein essential for electron transport in mitochondria and cell apoptosis."
    explanation: Identifies CYCS as the causal gene and cytochrome c as an electron-transfer and apoptosis protein.
  downstream:
  - target: Reduced Respiration and Increased Apoptotic Activity
    causal_link_type: DIRECT
    description: >-
      CYCS variants alter both electron-transfer/bioenergetic behavior and
      apoptotic activity of cytochrome c.
- name: Reduced Respiration and Increased Apoptotic Activity
  role: central_effector
  description: >-
    Functional studies of thrombocytopenia-associated CYCS variants show reduced
    respiratory performance alongside increased apoptotic activity. This
    distinguishes CYCS-related thrombocytopenia from classic Complex IV
    assembly deficiency: cytochrome c is affected, but patients generally do not
    show a syndromic cytochrome c oxidase deficiency phenotype.
  cell_types:
  - preferred_term: megakaryocyte
    term:
      id: CL:0000556
      label: megakaryocyte
  biological_processes:
  - preferred_term: respiratory electron transport chain
    term:
      id: GO:0022904
      label: respiratory electron transport chain
    modifier: DECREASED
  - preferred_term: positive regulation of apoptotic process
    term:
      id: GO:0043065
      label: positive regulation of apoptotic process
    modifier: INCREASED
  evidence:
  - reference: PMID:24326104
    reference_title: "Mutations of cytochrome c identified in patients with thrombocytopenia THC4 affect both apoptosis and cellular bioenergetics."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "we found reduction of respiratory level and increased apoptotic rate, supporting the pathogenetic role of CYCS in thrombocytopenia."
    explanation: Yeast and mouse cellular models directly support reduced respiration and increased apoptosis downstream of thrombocytopenia-associated CYCS variants.
  - reference: PMID:18345000
    reference_title: "A mutation of human cytochrome c enhances the intrinsic apoptotic pathway but causes only thrombocytopenia."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "The mutation yields a cytochrome c variant with enhanced apoptotic activity in vitro."
    explanation: The original CYCS G41S study supports enhanced apoptotic activity as a variant effect.
  downstream:
  - target: Dysregulated Megakaryocyte Platelet Release
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - altered cytochrome c respiratory function
    - enhanced intrinsic apoptotic signaling
    description: >-
      Altered cytochrome c function perturbs megakaryocyte platelet-release
      behavior, with premature platelet-like release in the marrow space.
- name: Dysregulated Megakaryocyte Platelet Release
  role: central_effector
  description: >-
    Patient studies indicate that circulating proplatelet formation can remain
    effective, but CYCS-mutant megakaryocytes also release platelet-like
    structures prematurely into extravascular bone marrow regions. Platelet-like
    structures released outside the vascular space lack a normal marginal
    microtubule coil, making them ineffective contributors to the circulating
    platelet pool.
  cell_types:
  - preferred_term: megakaryocyte
    term:
      id: CL:0000556
      label: megakaryocyte
  - preferred_term: platelet
    term:
      id: CL:0000233
      label: platelet
  biological_processes:
  - preferred_term: platelet formation
    term:
      id: GO:0030220
      label: platelet formation
  evidence:
  - reference: PMID:27861742
    reference_title: "Megakaryocytes from CYCS mutation-associated thrombocytopenia release platelets by both proplatelet-dependent and -independent processes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "the low platelet phenotype in Thrombocytopenia Cargeeg subjects is caused by premature release of platelets into non-vascular regions of the bone marrow."
    explanation: Patient marrow observations support premature extravascular platelet release as a mechanism for low circulating platelet count.
  - reference: PMID:27861742
    reference_title: "Megakaryocytes from CYCS mutation-associated thrombocytopenia release platelets by both proplatelet-dependent and -independent processes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "platelet-like structures within the extravascular bone marrow space have the dimensions of platelets but lack the marginal microtubule coil, suggesting abnormal proplatelet-independent platelet release."
    explanation: The abnormal extravascular platelet-like structures provide a tissue-level link from CYCS-mutant megakaryocytes to reduced effective platelet production.
  downstream:
  - target: Thrombocytopenia
    causal_link_type: DIRECT
    description: >-
      Premature or misplaced platelet-like release reduces the number of mature
      platelets reaching the circulation.
phenotypes:
- name: Thrombocytopenia
  category: Hematologic
  description: >-
    Mild-to-moderate isolated thrombocytopenia with normal platelet size and
    generally low bleeding risk.
  phenotype_term:
    preferred_term: Thrombocytopenia
    term:
      id: HP:0001873
      label: Thrombocytopenia
  evidence:
  - reference: PMID:38815995
    reference_title: "Thrombocytopenia 4 (THC4): Six novel families with mutations of the cytochrome c gene."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "mild-to-moderate thrombocytopenia, normal platelet size, and function, low risk of bleeding, and no additional clinical phenotypes associated with reduced platelet count."
    explanation: The largest reported THC4 cohort defines the characteristic platelet phenotype.
  - reference: PMID:35126455
    reference_title: "A Novel Heterozygous Pathogenic Variation in CYCS Gene Cause Autosomal Dominant Non-Syndromic Thrombocytopenia 4 in a Large Chinese Family."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The platelet counts of the patients were varied, ranging from 38 to 110 × 109/L (reference range: 150-450 x 109/L)."
    explanation: A three-generation CYCS family documents reduced platelet counts in affected individuals.
genetic:
- name: CYCS pathogenic variants causing thrombocytopenia 4
  gene_term:
    preferred_term: CYCS
    term:
      id: hgnc:19986
      label: CYCS
  inheritance:
  - name: Autosomal dominant
    evidence:
    - reference: PMID:35126455
      reference_title: "A Novel Heterozygous Pathogenic Variation in CYCS Gene Cause Autosomal Dominant Non-Syndromic Thrombocytopenia 4 in a Large Chinese Family."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "A novel heterozygous missense variant c.79C > T (p.His27Tyr) was identified in CYCS gene associated with autosomal dominant thrombocytopenia."
      explanation: A heterozygous CYCS missense variant segregated with autosomal-dominant thrombocytopenia in a three-generation family.
  variants:
  - name: CYCS p.Gly41Ser
    description: >-
      The original New Zealand family variant; it alters cytochrome c and
      enhances intrinsic apoptotic activity in vitro.
    gene:
      preferred_term: CYCS
      term:
        id: hgnc:19986
        label: CYCS
    evidence:
    - reference: PMID:18345000
      reference_title: "A mutation of human cytochrome c enhances the intrinsic apoptotic pathway but causes only thrombocytopenia."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Glycine 41, invariant throughout eukaryotes, is substituted by serine in a family with autosomal dominant thrombocytopenia caused by dysregulated platelet formation."
      explanation: Identifies CYCS p.Gly41Ser as the original family variant associated with autosomal-dominant thrombocytopenia.
  - name: CYCS p.His27Tyr
    description: >-
      A heterozygous CYCS missense variant reported in a large Chinese family
      with autosomal-dominant non-syndromic thrombocytopenia 4.
    gene:
      preferred_term: CYCS
      term:
        id: hgnc:19986
        label: CYCS
    evidence:
    - reference: PMID:35126455
      reference_title: "A Novel Heterozygous Pathogenic Variation in CYCS Gene Cause Autosomal Dominant Non-Syndromic Thrombocytopenia 4 in a Large Chinese Family."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "A novel heterozygous missense variant c.79C > T (p.His27Tyr) was identified in CYCS gene associated with autosomal dominant thrombocytopenia."
      explanation: Identifies p.His27Tyr as a CYCS variant associated with autosomal-dominant thrombocytopenia in a three-generation family.
  features: >-
    Heterozygous CYCS missense variants cause autosomal-dominant
    thrombocytopenia 4. Reported pathogenic variants cluster in regions that
    affect cytochrome c functions in apoptosis and mitochondrial respiration,
    with variable severity of platelet count reduction.
treatments:
- name: Genetic Counseling
  description: >-
    Counseling for autosomal-dominant transmission and family testing where a
    pathogenic CYCS variant has been identified.
  treatment_term:
    preferred_term: genetic counseling
    term:
      id: MAXO:0000079
      label: genetic counseling
notes: >-
  The seed label "mitochondrial cytochrome c deficiency" was not used as the
  disease name because independent MONDO, OMIM, Orphanet, and PubMed evidence
  identify OMIM:612004 / ORPHA:168629 as CYCS-related thrombocytopenia 4. This
  entry therefore models the CYCS/cytochrome c mechanism leading to
  thrombocytopenia and intentionally does not add CYCS to the mitochondrial
  Complex IV deficiency grouping.